Follow Me on Pinterest

Wednesday, August 22, 2012

Updated late-stage industry-sponsored cell therapy trial listing.


We've just updated our listing of industry-sponsored pivotal, ph3 and 2/3 cell therapy trials again.  See the posting here.

According to our data, approximately 50% of these trials are expected to have reached their estimated primary completion date or some other meaningful trial completion point within the next 12 months.

1 comment:

Anonymous said...

thanks for posting.